SENSEONICS HOLDINGS INC (SENS) Stock Price & Overview
NASDAQ:SENS • US81727U3032
Current stock price
The current stock price of SENS is 6.48 USD. Today SENS is up by 1.73%. In the past month the price decreased by -20.59%. In the past year, price decreased by -56.26%.
SENS Key Statistics
- Market Cap
- 270.67M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.70
- Dividend Yield
- N/A
SENS Stock Performance
SENS Stock Chart
SENS Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to SENS. When comparing the yearly performance of all stocks, SENS is a bad performer in the overall market: 85.94% of all stocks are doing better.
SENS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to SENS. SENS has a bad profitability rating. Also its financial health evaluation is rather negative.
SENS Earnings
On March 2, 2026 SENS reported an EPS of -0.47 and a revenue of 14.26M. The company missed EPS expectations (-6.1% surprise) and missed revenue expectations (-2.52% surprise).
SENS Forecast & Estimates
14 analysts have analysed SENS and the average price target is 19.3 USD. This implies a price increase of 197.76% is expected in the next year compared to the current price of 6.48.
For the next year, analysts expect an EPS growth of -70.43% and a revenue growth 67.25% for SENS
SENS Groups
Sector & Classification
SENS Financial Highlights
Over the last trailing twelve months SENS reported a non-GAAP Earnings per Share(EPS) of -1.7. The EPS increased by 29.17% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -54.73% | ||
| ROE | -113.21% | ||
| Debt/Equity | 0.58 |
SENS Ownership
SENS Latest News, Press Relases and Analysis
SENS Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.36 | 183.255B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.76 | 169.761B | ||
| SYK | STRYKER CORP | 22.19 | 128.458B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.87 | 103.101B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.38 | 47.916B | ||
| IDXX | IDEXX LABORATORIES INC | 38.94 | 45.961B | ||
| BDX | BECTON DICKINSON AND CO | 11.31 | 43.887B | ||
| RMD | RESMED INC | 18.4 | 32.922B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.48 | 31.743B | ||
| DXCM | DEXCOM INC | 26.33 | 25.766B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.36 | 17.192B | ||
| HOLX | HOLOGIC INC | 15.36 | 16.835B | ||
| PODD | INSULET CORP | 35.13 | 15.988B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About SENS
Company Profile
Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. The company is headquartered in Germantown, Maryland and currently employs 130 full-time employees. The company went IPO on 2015-03-04. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.
Company Info
IPO: 2015-03-04
SENSEONICS HOLDINGS INC
20451 Seneca Meadows Pkwy
Germantown MARYLAND 20876 US
CEO: Timothy T. Goodnow
Employees: 130
Phone: 13015157260
SENSEONICS HOLDINGS INC / SENS FAQ
Can you describe the business of SENSEONICS HOLDINGS INC?
Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. The company is headquartered in Germantown, Maryland and currently employs 130 full-time employees. The company went IPO on 2015-03-04. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.
Can you provide the latest stock price for SENSEONICS HOLDINGS INC?
The current stock price of SENS is 6.48 USD. The price increased by 1.73% in the last trading session.
Does SENS stock pay dividends?
SENS does not pay a dividend.
What is the ChartMill technical and fundamental rating of SENS stock?
SENS has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the market expecting SENS stock to perform?
14 analysts have analysed SENS and the average price target is 19.3 USD. This implies a price increase of 197.76% is expected in the next year compared to the current price of 6.48.
What is the Price/Earnings (PE) ratio of SENSEONICS HOLDINGS INC (SENS)?
SENSEONICS HOLDINGS INC (SENS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.7).
When does SENSEONICS HOLDINGS INC (SENS) report earnings?
SENSEONICS HOLDINGS INC (SENS) will report earnings on 2026-05-06.